Climb Biotherapeutics, Inc. (CLYM)
Market Open
15 Jun, 14:46
NASDAQ (NMS) NASDAQ (NMS) Primary $
11. 52
+0.08
+0.6993%
$
780.03M Market Cap
- P/E Ratio
- Div Yield
126,459 Volume
0 Eps
$ 11.44
Previous Close 
Want to track CLYM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
CLYM Earnings Reports FAQ
What is the earnings per share (EPS) for CLYM?
The current EPS is 0.
What is the company's earnings growth rate?
Climb Biotherapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Climb Biotherapeutics, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Climb Biotherapeutics, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for CLYM at this time, as Climb Biotherapeutics, Inc has no recent EPS data to calculate it.
